ArticleIndian journal of psychiatry2025
Inflammatory markers and cognitive deficits in first-episode psychoses - A cross-sectional study.
Article in Indian journal of psychiatry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Inflammation's complex role in first-episode psychoses.Indian journal of psychiatry · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The first episode psychosis (FEP) is diagnosed when an individual exhibits signs of psychosis for the first time in a clinical setting. Various studies have observed elevated inflammatory markers such as C-reactive protein (CRP), Interleukin (IL)-6, IL-1B, Tumor Necrosis Factor (TNF) alpha, erythrocyte sedimentation rate (ESR), and neutrophil-lymphocyte ratio (NLR) in FEP. Cognitive deficits manifest early in patients with psychosis and contribute to poor clinical outcomes. Research indicates that cognitive deficits are linked to increased inflammatory biomarkers IL-6, IL1B, TNF-alpha, CRP). Aim: To evaluate the serum levels of inflammatory markers and severity of cognitive impairment in individuals with first-episode psychoses and to identify any potential associations between inflammatory markers and cognitive decline. Methods: Fifty drug-naïve patients with FEP visiting the department of Psychiatry at a tertiary care hospital were enrolled following permission from the Institutional Ethics Committee. After obtaining informed consent, they were interviewed using a semi-structured proforma and assessed using DSM-5. The Montreal Cognitive Assessment (MoCA) scale and Mini-Mental Status Examination (MMSE) assessed cognitive deficits. CRP, ESR, and NLR levels were measured, and the data collected were tabulated and statistically analyzed. Result: Out of 50 participants, 46% had elevated serum CRP levels, and 90% had elevated Neutrophil Lymphocyte Ratio levels well above clinical cut-offs. Most participants had normal ESR levels, and no vital association was seen between raised inflammatory markers and cognitive deficits. Conclusion: Patients with First Episode Psychosis had raised levels of inflammatory markers like CRP and NLR. This could be due to neuroinflammation, contributing to the development of psychosis. The study observed cognitive deficits in First Episode Psychosis to be poorly associated with inflammatory markers.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.